Cost-utility analysis for UTIs
Schaefer, S.E.
Journal of Family Practice 44(4): 329
1997
ISSN/ISBN: 0094-3509 PMID: 9108820 Document Number: 472423
Document emailed within 1 workday
Related Documents
Turajane, T.; Chaweevanakorn, U.; Sungkhun, P.; Larbphiboonpong, V.; Wongbunnak, R. 2012: Cost-utility analysis and economic burden of knee osteoarthritis treatment: the analysis from the real clinical practice Journal of the Medical Association of Thailand 95(Suppl 10): S98-104Wajanavisit, W.; Woratanarat, P.; Sawatriawkul, S.; Lertbusayanukul, C.; Ongphiphadhanakul, B. 2015: Cost-Utility Analysis of Osteoporotic Hip Fractures in Thais Journal of the Medical Association of Thailand 98(Suppl 8): S65-S69
Holtgrave, D.R.; Maulsby, C.; Kharfen, M.; Jia, Y.; Wu, C.; Opoku, J.; West, T.; Pappas, G. 2012: Cost-utility analysis of a female condom promotion program in Washington, DC Aids and Behavior 16(5): 1115-1120
Grocott, R.; Metcalfe, S.; Alexander, P.; Werner, R. 2013: Assessing the value for money of pharmaceuticals in new Zealand--PHARMAC's approach to cost-utility analysis New Zealand Medical Journal 126(1378): 60-73
Avritscher, E.B.C.; Shih, Y-Chen.T.; Sun, C.C.; Gralla, R.J.; Grunberg, S.M.; Xu, Y.; Elting, L.S. 2010: Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients Journal of Supportive Oncology 8(6): 242-251
Roungrong, J.; Teerawattananon, Y.; Chaikledkaew, U. 2008: Cost-utility analysis of recombinant human erythropoietin in anemic cancer patients induced by chemotherapy in Thailand Journal of the Medical Association of Thailand 91(Suppl 2): S119-S125
Rubio-Terrés, C.; Domínguez-Gil Hurlé, A. 2005: Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain Revista de Neurologia 40(12): 705-710
Sangchan, A.; Chaiyakunapruk, N.; Supakankunti, S.; Pugkhem, A.; Mairiang, P. 2014: Cost utility analysis of endoscopic biliary stent in unresectable hilar cholangiocarcinoma: decision analytic modeling approach Hepato-Gastroenterology 61(133): 1175-1181
Richter, J.M.; Christensen, M.R.; Rustgi, A.K.; Silverstein, M.D. 1989: The clinical utility of the Ca19-9 radioimmunoassay for the diagnosis of pancreatic cancer presenting as pain or weight loss. a cost-effectiveness analysis Archives of Internal Medicine 149(10): 2292-2297
Kawalec, P.ł; Holko, P.ła.; Szkultecka-Debek, M.; Paszulewicz, A.; Boratyńska, M.; Głyda, M.; Ignacak, E.; Maks, J.; Russel-Szymczyk, M.; Kaweczyńska-Lasoń, A. 2013: The evaluation of cost-effectiveness and cost-utility of valganciclovir for the prophylaxis of cytomegalovirus disease to 200 days after kidney transplantation Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 34(204): 332-338
Bischoff, D. 1998: Plugging drains. Utility managers offer cost control Modern Healthcare 28(26): 98; 102
Grocott, R.; Metcalfe, S. 2012: PHARMAC's updated guidelines for cost-utility analyses, with new QALYs per $1M metric New Zealand Medical Journal 125(1358): 89-90
Richards, R.; Burls, A.; Payne, N. 2000: Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit Bmj 320(7247): 1475; Author Reply 1475-6
Block, E.F.; Singh, I.; Thompson, E. 1998: Utility and cost-savings of diagnostic laparoscopy in low-probability gunshot wounds of the abdomen Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 150(5): 232-234
Odocha, O.; Kelly, B.; Trimble, S.; Murigande, C.; Toussaint, R.M.; Callender, C.O. 1996: Cost-containment strategies in transplantation: the utility of cyclosporine-ketoconazole combination therapy Transplantation Proceedings 28(2): 907-909
de Souza, P. 1993: A cost-utility approach to the use of 5-fluorouracil and levamisole as adjuvant chemotherapy for Dukes' C colonic carcinoma Medical Journal of Australia 158(12): 866
Deirdre Wulf 1981: Cost-Benefit and Cost-Effectiveness Analysis for Family Planning Programs International Family Planning Perspectives 7(4): 141-144
Merritt, T.A.; Hallman, M.; Vaucher, Y.; McFeeley, E.; Tubman, T.R. 1990: Impact of surfactant treatment on cost of neonatal intensive care: a cost-benefit analysis Journal of Perinatology: Official Journal of the California Perinatal Association 10(4): 416-419
Vasu, V.; Jadresic, L.P. 2005: Managing UTIs in children Practitioner 249(1671): 457-460
Fuller, J.F. 1974: Cost-benefit and cost-effectiveness analysis New Zealand Dental Journal 70(322): 282-288